Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prognostic Impact of Sleep Apnea on Cardiovascular Morbidity and Mortality, in End Stage Renal Disease Patients (SASinHD_003)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Centre Hospitalier Universitaire Vaudois
Sponsor:
Information provided by (Responsible Party):
Adam Ogna, Centre Hospitalier Universitaire Vaudois
ClinicalTrials.gov Identifier:
NCT02073305
First received: February 25, 2014
Last updated: January 26, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)